CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 21,400 full-time employees. The firm operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The firm conducts its business in the domestic and overseas markets.
How did CSPCY's recent EPS compare to expectations?
The most recent EPS for CSPC Pharmaceutical Group Limited is $0.03, not beating expectations of $0.13.
How did CSPC Pharmaceutical Group Limited CSPCY's revenue perform in the last quarter?
CSPC Pharmaceutical Group Limited revenue for the last quarter is $0.03
What is the revenue estimate for CSPC Pharmaceutical Group Limited?
According to 4 of Wall street analyst, the revenue estimate of CSPC Pharmaceutical Group Limited range from $11.79B to $7.88B
What's the earning quality score for CSPC Pharmaceutical Group Limited?
CSPC Pharmaceutical Group Limited has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does CSPC Pharmaceutical Group Limited report earnings?
CSPC Pharmaceutical Group Limited next earnings report is expected in 2026-06-23
What are CSPC Pharmaceutical Group Limited's expected earnings?
CSPC Pharmaceutical Group Limited expected earnings is $8.66B, according to wall-street analysts.
Did CSPC Pharmaceutical Group Limited beat earnings expectations?
CSPC Pharmaceutical Group Limited recent earnings of $6.11B does not beat expectations.